Monopar Therapeutics MNPR
NASDAQ MNPR
$73.75 +2.33 (+3.26%)
At close: Nov 9, 2026 · 4:00 PM EST

Monopar Therapeutics (MNPR) Acquisitions (2017)

Updated

Monopar Therapeutics (MNPR) posted Acquisitions of -$1.00 for Q4 2017.

Analysis

Monopar Therapeutics (MNPR) Acquisitions (2017) Analysis & Trends

For FY2017, Monopar Therapeutics' Acquisitions came in at -$4.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -17.15 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 10.59 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Monopar Therapeutics 630.69 Mn 335.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -1.00
API Access

Monopar Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=MNPR&period=max&api_key=YOUR_API_KEY